Home Capital Broker's Calls

Growth is a given for this leading healthcare stock, but the risks are still aplenty

Michelle Zhu
Michelle Zhu6/5/2017 1:19 PM GMT+08  • 2 min read
Growth is a given for this leading healthcare stock, but the risks are still aplenty
SINGAPORE (June 5): Maybank Kim Eng Research is maintaining its “hold” call on IHH Healthcare with a higher price target of RM6.17 ($2) from RM5.62 previously, highlighting the stock as a healthcare leader in the premium hospital segment with a strong
Font Resizer
Share to WhatsappShare to FacebookShare to LinkedInMore Share
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

SINGAPORE (June 5): Maybank Kim Eng Research is maintaining its “hold” call on IHH Healthcare with a higher price target of RM6.17 ($2) from RM5.62 previously, highlighting the stock as a healthcare leader in the premium hospital segment with a strong brand name.

The counter continues to trade at a premium of 22 times FY17E EV/EBITDA, versus 20 times for its regional peers.

In a Monday report, analyst John Cheong notes that aside from being a proxy to the premium healthcare space in countries with rapidly growing demand, the group also has a strong track record of building up operations in markets lacking medical-pricing regulations.

For more insights on corporate trends...
Sign In or Create an account to access our premium content.
Subscription Entitlements:
Less than $9 per month
Unlimited access to latest and premium articles
3 Simultaneous logins across all devices
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)
×
Loading next article...
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
Subscribe to The Edge Singapore
Get credible investing ideas from our in-depth stock analysis, interviews with key executives, corporate movements coverage and their impact on the market.
© 2022 The Edge Publishing Pte Ltd. All rights reserved.